newsfilter
← Latest News
GlobeNewswire·

Lucira Health Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

EMERYVILLE, Calif., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. ("Lucira Health" or "Lucira") (NASDAQ:LHDX), a medical technology company focused on the development and commercialization of innovative infectious disease tests today announced